🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
313,52 USD
Máx. histórico
322,75
4 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-2,86%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,12%
Cierre anterior
307,02
Rango de hoy
309,46 – 317,76
Volumen hoy
195.564
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 33,04 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 9 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 12/06/2024 | 80,59 | 81,89 | 80,15 | 80,15 | +0,06% | 2,16% | 80.600 |
| 11/06/2024 | 78,85 | 80,42 | 77,51 | 80,10 | +0,72% | 3,69% | 114.200 |
| 10/06/2024 | 80,61 | 80,61 | 77,43 | 79,53 | -2,25% | 3,94% | 136.800 |
| 07/06/2024 | 81,38 | 82,20 | 79,69 | 81,36 | -1,23% | 3,08% | 142.500 |
| 06/06/2024 | 83,41 | 83,41 | 81,49 | 82,37 | -1,47% | 2,30% | 96.500 |
| 05/06/2024 | 81,22 | 84,15 | 80,31 | 83,60 | +3,43% | 4,73% | 85.800 |
| 04/06/2024 | 86,82 | 87,03 | 79,50 | 80,83 | -8,05% | 8,67% | 203.300 |
| 03/06/2024 | 85,44 | 88,73 | 85,29 | 87,91 | +3,36% | 4,03% | 128.600 |
| 31/05/2024 | 84,53 | 86,82 | 84,32 | 85,05 | +1,30% | 2,96% | 122.300 |
| 30/05/2024 | 85,61 | 85,61 | 83,09 | 83,96 | -1,17% | 2,94% | 152.400 |
| 29/05/2024 | 84,27 | 85,19 | 83,68 | 84,95 | -1,20% | 1,79% | 107.500 |
| 28/05/2024 | 86,40 | 86,86 | 84,13 | 85,98 | -0,49% | 3,16% | 108.100 |
| 24/05/2024 | 85,60 | 86,65 | 84,68 | 86,40 | +1,75% | 2,30% | 160.600 |
| 23/05/2024 | 87,22 | 87,48 | 83,17 | 84,91 | -2,72% | 4,94% | 125.700 |
| 22/05/2024 | 87,01 | 88,22 | 86,94 | 87,28 | +0,32% | 1,47% | 111.800 |
| 21/05/2024 | 86,50 | 88,52 | 86,42 | 87,00 | +0,43% | 2,43% | 171.700 |
| 20/05/2024 | 85,87 | 87,29 | 85,87 | 86,63 | +0,66% | 1,65% | 105.200 |
| 17/05/2024 | 85,53 | 86,90 | 85,17 | 86,06 | +1,22% | 2,02% | 100.200 |
| 16/05/2024 | 85,40 | 86,77 | 84,14 | 85,02 | -0,87% | 3,08% | 95.100 |
| 15/05/2024 | 86,00 | 86,68 | 84,80 | 85,77 | +0,56% | 2,19% | 164.700 |
| 14/05/2024 | 84,56 | 85,76 | 84,54 | 85,29 | +1,45% | 1,44% | 160.400 |
| 13/05/2024 | 87,34 | 87,53 | 83,93 | 84,07 | -3,68% | 4,12% | 105.200 |
| 10/05/2024 | 85,53 | 87,33 | 84,05 | 87,28 | +1,35% | 3,83% | 131.500 |
| 09/05/2024 | 79,27 | 86,37 | 79,27 | 86,12 | +7,17% | 8,96% | 494.200 |
| 08/05/2024 | 74,37 | 81,43 | 72,95 | 80,36 | +9,75% | 11,40% | 286.900 |
| 07/05/2024 | 73,50 | 75,61 | 73,16 | 73,22 | +0,54% | 3,33% | 162.700 |
| 06/05/2024 | 74,05 | 74,70 | 72,61 | 72,83 | -1,45% | 2,82% | 114.800 |
| 03/05/2024 | 73,53 | 74,17 | 72,57 | 73,90 | +2,18% | 2,18% | 141.800 |
| 02/05/2024 | 71,77 | 72,70 | 70,86 | 72,32 | +1,26% | 2,56% | 146.500 |
| 01/05/2024 | 70,12 | 72,17 | 69,51 | 71,42 | +2,19% | 3,79% | 115.900 |